Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.
Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses.
复制标题
白细胞介素 12 治疗皮肤 T 细胞淋巴瘤可诱导病变消退和细胞毒性 T 细胞反应。
作者：
Rook,AH;Wood,GS;Yoo,EK;Elenitsas,R;Kao,DM;Sherman,ML;Witmer,WK;Rockwell,KA;Shane,RB;Lessin,SR;Vonderheid,EC
